Genomics

Jumpcode Genomics Joins 10x Genomics’ Compatible Partner Program

Powerful combination of Jumpcode Single Cell RNA Boost Kit and 10x Genomics Chromium Single Cell Gene Expression platform enables scientists to boost single cell RNA sequencing

Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced a partnership with 10x Genomics to integrate the Jumpcode Single Cell RNA Boost Kit with the 10x Genomics Chromium Single Cell Gene Expression platform. Part of the Compatible Partner Program, the kit is verified with 10x Genomics’ workflows.

“We’re honored to join the distinguished 10x Genomics Compatible Partner Program, which underscores the potential of leveraging our CRISPRclean technology to break barriers in research,” said Yaron Hakak, Ph.D., CEO of Jumpcode Genomics. “Through this partnership, scientists using the 10x Genomics platform have the opportunity to significantly improve the sensitivity of single cell RNA sequencing and vastly increase the amount of usable data. By removing bias and simplifying workflows, together we’re providing scientists with the ability to extract greater insights from cells.”

An abundance of uninformative sequences can obscure valuable next-gen sequencing (NGS) data. Jumpcode’s CRISPRclean technology is changing that. Leveraging Cas9 and specifically designed guides, the Single Cell RNA Boost Kit degrades abundant, uninformative sequences in NGS libraries, redistributing 50% sequencing clusters to unique biologically relevant transcripts. Jumpcode’s solution has now been validated with 10x Genomics’ Chromium Single Cell 3′ Gene Expression microfluidic platform which enables researchers to scale experiments for single cell analysis. The combination of these two technologies empowers scientists to cut through sequencing noise and boost usable data.

“We are proud to welcome Jumpcode Genomics to the 10x Genomics Compatible Partner Program,” said Edwin Hauw, Vice President of Marketing for 10x Genomics. “We share a belief that single cell analysis is key to accelerating research that can advance healthcare, and the combination of our platform with Jumpcode’s kit will provide researchers with the novel technologies they need to uncover the next innovations in human health.”

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

Genomics Software, Allelica Raises $1.75M For PRS Analysis

Business Wire

Genomics Solutions Provider IDT Acquires Swift Biosciences

Business Wire

LifeMine Therapeutics Inc. collaborates with GlaxoSmithKline

Business Wire